Efficacy of Fullerene in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .

NACompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

May 1, 2025

Conditions
Radiation Dermatitis
Interventions
OTHER

Fullerene cream

Patients are instructed to apply a thin layer of the Fullerene cream third a day, starting three days before radiotherapy(RT) and continue until two weeks after treatment. The application should include the whole treatment area. Patients are also advised to not apply the cream within four hours before the RT in order to avoid possible build-up effect. Patients are asked to keep the skin of the radiotherapy area dry and clean and not use other topical agents in the irradiated area.

DRUG

Trolamine (Biafine)

Patients are instructed to apply a thin layer of the Trolamine (Biafine) third a day, starting three days before radiotherapy(RT) and continue until two weeks after treatment. The application should include the whole treatment area. Patients are also advised to not apply the cream within four hours before the RT in order to avoid possible build-up effect. Patients are asked to keep the skin of the radiotherapy area dry and clean and not use other topical agents in the irradiated area.

Trial Locations (1)

646000

West China Hospital, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER

NCT06484166 - Efficacy of Fullerene in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer . | Biotech Hunter | Biotech Hunter